Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome

Xinghong Zhou,Shuai Ji,Liqian Chen,Xiaoyu Liu,Yijian Deng,Yanting You,Ming Wang,Qiuxing He,Baizhao Peng,Ying Yang,Xiaohu Chen,Hiu Yee Kwan,Lin Zhou,Jieyu Chen,Xiaoshan Zhao
DOI: https://doi.org/10.1186/s40168-024-01826-9
IF: 15.5
2024-06-23
Microbiome
Abstract:The prevalence of hyperuricaemia (HUA), a metabolic disorder characterized by elevated levels of uric acid, is on the rise and is frequently associated with renal injury. Gut microbiota and gut-derived uremic toxins are critical mediators in the gut-kidney axis that can cause damage to kidney function. Gut dysbiosis has been implicated in various kidney diseases. However, the role and underlying mechanism of the gut microbiota in HUA-induced renal injury remain unknown.
microbiology
What problem does this paper attempt to address?
The paper primarily explores the mechanisms by which hyperuricaemia (HUA) affects kidney damage through altering the gut microbiota (gut microbiota dysbiosis) and the uremic toxins they produce, and investigates the relationship between this effect and NLRP3 inflammasome activation. ### Research Background - Hyperuricaemia is a metabolic disorder characterized by elevated levels of uric acid in the blood and is associated with various diseases, including gout, type 2 diabetes, cardiovascular diseases, and chronic kidney disease. - The gut microbiota plays a crucial role in maintaining health and is a key participant in the gut-kidney axis, playing an important role in kidney health. - Gut microbiota dysbiosis has been shown to be associated with various kidney diseases, leading to increased production of uremic toxins such as indoxyl sulfate (IS), p-cresyl sulfate (PCS), and trimethylamine N-oxide (TMAO). - Although studies have shown differences in gut microbiota between HUA patients and healthy controls, the specific role and potential mechanisms of HUA-induced gut microbiota dysbiosis in the development of kidney damage remain unclear. ### Main Findings - By constructing a uricase gene knockout rat model (UOX−/−), researchers found that these rats exhibited significant hyperuricaemia and renal insufficiency. - Significant renal histopathological damage was observed in UOX−/− rats, including tubular injury, fibrosis, and inflammatory cell infiltration. - 16S rRNA sequencing analysis showed significant changes in the gut microbiota of UOX−/− rats, particularly an increase in the abundance of certain harmful bacteria and a decrease in beneficial bacteria. - Functional predictions indicated that metabolic pathways related to uremic toxin production were activated in UOX−/− rats. - Metabolomics analysis revealed a significant increase in gut-derived uremic toxins in the kidneys of UOX−/− rats. - Fecal microbiota transplantation experiments further confirmed that the gut microbiota from HUA rats could exacerbate kidney damage in recipient mice after ischemia/reperfusion (I/R) surgery and promote NLRP3 inflammasome activation. - In NLRP3 gene knockout mice, the kidney damage effects induced by the HUA microbiota disappeared, indicating that NLRP3 inflammasome activation plays a key role in this process. ### Conclusion In summary, this study reveals that hyperuricaemia-induced gut microbiota dysbiosis can promote the production of uremic toxins, thereby activating the NLRP3 inflammasome, ultimately leading to kidney damage. These findings provide a theoretical basis for developing new therapies targeting the gut microbiota and NLRP3 inflammasome.